Tower Research Capital LLC (Trc) Alector, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Alector, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,574 shares of ALEC stock, worth $15,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,574

Previous 18,411 53.43%

Holding current value

$15,861

Previous $83,000 51.81%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.34 - $6.58 $42,692 - $64,727	-9,837 Reduced 53.43%	8,574 $40,000
Q2 2024 Aug 13, 2024	BUY	$4.19 - $6.23 $73,463 - $109,230	17,533 Added 1996.92%	18,411 $83,000
Q1 2024 May 15, 2024	SELL	$5.69 - $8.08 $81,941 - $116,360	-14,401 Reduced 94.25%	878 $5,000
Q4 2023 Feb 13, 2024	BUY	$3.77 - $8.39 $53,337 - $118,701	14,148 Added 1250.93%	15,279 $121,000
Q3 2023 Nov 14, 2023	SELL	$5.2 - $8.77 $15,797 - $26,643	-3,038 Reduced 72.87%	1,131 $7,000
Q2 2023 Aug 14, 2023	SELL	$5.86 - $7.93 $2,355 - $3,187	-402 Reduced 8.79%	4,169 $25,000
Q1 2023 May 09, 2023	BUY	$5.85 - $9.84 $20,790 - $34,971	3,554 Added 349.46%	4,571 $28,000
Q4 2022 Feb 10, 2023	SELL	$6.88 - $9.55 $157,386 - $218,465	-22,876 Reduced 95.74%	1,017 $9,000
Q3 2022 Nov 10, 2022	BUY	$8.19 - $13.2 $110,016 - $177,315	13,433 Added 128.42%	23,893 $226,000
Q2 2022 Aug 15, 2022	SELL	$7.65 - $14.24 $48,860 - $90,950	-6,387 Reduced 37.91%	10,460 $106,000
Q1 2022 May 12, 2022	BUY	$13.02 - $20.78 $116,164 - $185,399	8,922 Added 112.58%	16,847 $240,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $52,941 - $69,877	-2,736 Reduced 25.66%	7,925 $164,000
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $48,993 - $89,365	2,263 Added 26.95%	10,661 $243,000
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $97,014 - $140,702	6,259 Added 292.61%	8,398 $175,000
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $123,364 - $184,797	-8,313 Reduced 79.54%	2,139 $43,000
Q4 2020 Feb 16, 2021	BUY	$9.4 - $16.7 $49,979 - $88,793	5,317 Added 103.54%	10,452 $158,000
Q3 2020 Nov 16, 2020	SELL	$10.54 - $24.96 $30,998 - $73,407	-2,941 Reduced 36.42%	5,135 $54,000
Q2 2020 Aug 13, 2020	BUY	$21.87 - $33.11 $176,622 - $267,396	8,076 New	8,076 $197,000
Q1 2020 May 15, 2020	SELL	$16.25 - $35.28 $4,875 - $10,584	-300 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$14.17 - $20.3 $4,251 - $6,090	300 New	300 $5,000
Q3 2019 Nov 05, 2019	SELL	$14.42 - $22.2 $1,442 - $2,220	-100 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$16.26 - $26.42 $43,593 - $70,832	-2,681 Reduced 96.4%	100 $2,000
Q1 2019 May 14, 2019	BUY	$15.97 - $22.5 $44,412 - $62,572	2,781 New	2,781 $52,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $153M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Alector, Inc. Transaction History